| 44.69 Delayed Data As of Oct 23 |  +0.77 / +1.75%Today’s Change | 35.30 Today|||52-Week Range 46.22 | +17.67% Year-to-Date |
| Are These 3 Beaten-Down Biotech Stocks Bargains Now? Oct 17 / MotleyFool.com - Paid Partner Content | Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding? Oct 11 / MotleyFool.com - Paid Partner Content |
| Previous close | 43.92 |
| Today’s open | 44.51 |
| Day’s range | 44.28 - 44.74 |
| Volume | 3,703,499 |
| Average volume (3 months) | 3,119,831 |
| Market cap | $115.1B |
| Earnings growth (last year) | -29.11% |
| Earnings growth (this year) | +3.84% |
| Earnings growth (next 5 years) | +16.55% |
| Revenue growth (last year) | -2.88% |
| P/E ratio | 52.0 |
| Price/Sales | 4.36 |
| Price/Book | 8.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.12 | -0.15% |
| SNYSanofi | +0.45 | +0.99% |
| GSKGlaxoSmithKline | +0.75 | +1.76% |
| LLYEli Lilly and Co | -2.44 | -2.22% |
| Last reporting date | October 24, 2019 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $22.1B |
| Annual profit (last year) | $2.2B |
| Net profit margin | 9.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
